Spots Global Cancer Trial Database for leukemia, myelogenous, chronic
Every month we try and update this database with for leukemia, myelogenous, chronic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) | NCT00129740 | Leukemia, Myelo... | Nilotinib | 16 Years - | M.D. Anderson Cancer Center | |
| Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) | NCT03421626 | Leukemia, Myelo... | Xpert BCR-ABL U... | 18 Years - 100 Years | Cepheid | |
| Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) | NCT00129740 | Leukemia, Myelo... | Nilotinib | 16 Years - | M.D. Anderson Cancer Center | |
| A Bioequivalence Study of Dasatinib Tablet | NCT05640804 | Leukemia, Myelo... | CTTQ Dasatinib ... Sprycel Dasatin... | 18 Years - 55 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Bioequivalence Study of Dasatinib Tablet | NCT05640804 | Leukemia, Myelo... | CTTQ Dasatinib ... Sprycel Dasatin... | 18 Years - 55 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation | NCT02117115 | Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... Multiple Myelom... | Dynamic contras... Ioversol | 20 Years - 60 Years | Washington University School of Medicine | |
| A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies | NCT00569179 | Leukemia, Myelo... Leukemia, Lymph... Myelodysplastic... Leukemia, Myelo... | CliniMACS CD34 ... | 18 Years - 65 Years | Indiana University | |
| Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation | NCT02117115 | Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... Multiple Myelom... | Dynamic contras... Ioversol | 20 Years - 60 Years | Washington University School of Medicine | |
| An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® | NCT02455024 | Myeloid Leukemi... | 18 Years - | Takeda | ||
| An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® | NCT02455024 | Myeloid Leukemi... | 18 Years - | Takeda | ||
| Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) | NCT00129740 | Leukemia, Myelo... | Nilotinib | 16 Years - | M.D. Anderson Cancer Center | |
| AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™ | NCT00058747 | Leukemia, Myelo... | Autologous HSP-... | 18 Years - | Agenus Inc. | |
| Sitagliptin Umbilical Cord Blood Transplant Study | NCT00862719 | Leukemia, Myelo... Acute Lymphobla... Myelodysplasia Leukemia, Myelo... Lymphoma, Non-H... | Sitagliptin | 18 Years - 59 Years | Indiana University | |
| Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies | NCT00619879 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... Myeloproliferat... Lymphoma, Malig... | Myeloablative C... Myeloablative C... Hematopoietic P... CNS radiation t... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® | NCT02455024 | Myeloid Leukemi... | 18 Years - | Takeda | ||
| A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies | NCT00569179 | Leukemia, Myelo... Leukemia, Lymph... Myelodysplastic... Leukemia, Myelo... | CliniMACS CD34 ... | 18 Years - 65 Years | Indiana University | |
| Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant | NCT01720264 | Acute Myeloid L... Acute Lymphoid ... Hematopoetic My... Leukemia, Myelo... Lymphoma, Non-H... | Sitagliptin | 18 Years - 60 Years | Indiana University | |
| A Bioequivalence Study of Dasatinib Tablet | NCT05640804 | Leukemia, Myelo... | CTTQ Dasatinib ... Sprycel Dasatin... | 18 Years - 55 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Bioequivalence Study of Dasatinib Tablet | NCT05640804 | Leukemia, Myelo... | CTTQ Dasatinib ... Sprycel Dasatin... | 18 Years - 55 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
